Insulin timing for severe stroke patients with high blood sugar
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares giving insulin early versus waiting a bit to lower blood sugar after a severe stroke. It may help understand the best timing to treat high blood sugar in this situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a severe stroke (either from a clot or bleeding) in the last 24 hours.
- Your blood sugar is above 180 mg/dL (10 mmol/L) at the time of joining the study.
- You do not have type 1 diabetes or a known allergy to insulin.
- You were able to walk and care for yourself before the stroke (no major disability).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called a GLP-1 receptor agonist (similar to diabetes drugs) can improve recovery after a specific type of bleeding stroke. The study aims to see if this drug can reduce brain swelling and help patients regain function.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This study tests whether a diabetes drug called a DPP4 inhibitor can help protect memory and thinking after a mild stroke. It is for people with type 2 diabetes who have had a stroke within the last two weeks.
This trial tests whether a medication commonly used for diabetes can help patients who had a stroke due to a blocked large artery in the brain. The drug is given as an injection after the standard procedure to remove the blood clot, and researchers will see if it leads to better recovery.
This trial tests a drug called urinary kallidinogenase in people who have had a stroke and also have type 2 diabetes. The drug may help improve recovery after a stroke.
This trial tests whether a medicine called an SGLT2 inhibitor, which is usually used for diabetes, can help protect the brain and improve recovery when given soon after a stroke. It is for people who had a stroke within the last 3 days and have moderate to severe symptoms.
Hear when a new Severe Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.